Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares
Stock Information for Corbus Pharmaceuticals Holdings Inc.
Loading
Please wait while we load your information from QuoteMedia.